Proteon Therapeutics
company
Funding Round
Series D
Money Raised
$ 45M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Abingworth | - | Yes | - | Detail |
| Life Sciences Fund | - | - | - | Detail |
| Inbio Ventures | - | - | - | Detail |
| Bessemer Venture Partners | - | - | - | Detail |
| Deepfield | - | - | - | Detail |
| Devon Park BioVentures | - | - | - | Detail |
| Intersouth Partners | - | - | - | Detail |
| MPM Capital | - | - | - | Detail |
| Pharmstandard | - | - | - | Detail |
| Prism Venture Management | - | - | - | Detail |
| Skyline Ventures | - | - | - | Detail |
| TVM Capital | - | - | - | Detail |
| Vectis Healthcare & Life Sciences Fund | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| May 28, 2009 | Series B | $ 50M | MPM Bio IV NVS Strategic Fund,Bessemer Venture Partners,etc. | Detail |
| Mar 30, 2006 | Series A | $ 19M | Intersouth Partners,Prism Venture Management,etc. | Detail |
| Feb 19, 2014 | Series Unknown | $ 4.33M | Detail | |
| Sep 6, 2007 | Series A | $ 12M | Bessemer Venture Partners,Devon Park BioVentures,etc. | Detail |
| Aug 12, 2011 | Series C | $ 15.20M | Bessemer Venture Partners,Devon Park BioVentures,etc. | Detail |
